1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Point-of-Care Drug Reconstitution Systems to 2020

Point-of-Care Drug Reconstitution Systems to 2020

  • January 2014
  • -
  • Greystone Research Associates

Growth in the number of injectable drugs supplied in solid form for reconstitution prior to administration is being driven by the increase in drugs based on biological NCEs. These drugs are typically unstable at ambient temperatures and to preserve their shelf life must be either stored at low temperature (the so-call 'cold chain') or processed into a form that will preserve their pharmacological efficacy until they reach their therapeutic destination. Because the cost of transporting and storing drugs using refrigeration is expensive and requires constant temperature monitoring to insure that the drug has not been exposed to environmental conditions that render unsafe for use as a therapeutic product, technologies such as lyophilization are becoming more prevalent. The packaging and technologies developed and marketed for safe and reliable reconstitution at the point of administration are benefiting from this market trend. This report examines commercial drug reconstitution devices and systems and their impact on the injectable drug delivery sector.

Highlights

- Analyzes therapeutic demand drivers and evaluates the market impact and potential of commercial drug reconstitution systems

- Provides analysis of injectable drugs for reconstitution and assesses key market segments, market dynamics and market demographics

- Forecasts Injectable drug product demand by indication and therapy to 2020

- Profiles reconstitution system suppliers, their product activities, business strategies, and corporate alliances and affiliations

Table Of Contents

Point-of-Care Drug Reconstitution Systems to 2020
Executive Summary

Market Dynamics
Prolonging the Shelf Life of Biological Drugs
Distribution Strategies
Formulation Strategies
Lyophilization and Reconstitution at the Point of Use
Healthcare Economics and Reconstitution Systems

What's Driving the Growth in Engineered Reconstitution Systems?
Biological Drugs Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors

Drug Reconstitution Systems - Commercial Devices
Vial Adapters
Vial-to-Vial Systems
Needle-less Transfer Devices
Direct Connect to Vial
Direct Connect to Cartridge
Dual Chamber Syringes
Dual Chamber Cartridges
Closed Drug Transfer
Reconstitution System Design Factors
Stability and Material Selection Issues
Disposable Drug Cartridges
Single vs Multi-Dose Devices
Human Engineering/Ergonomics

Drug Reconstitution - Therapeutic Sector Analysis

Market Factors

Drug Reconstitution Systems - Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Medical Ultrasound Devices: Technologies and Global Markets

Medical Ultrasound Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of medical ultrasound devices market. ...

European Market Report for Central Venous Catheters 2017 - MedCore

European Market Report for Central Venous Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European CVC market includes acute and chronic CVCs. Acute CVCs are classified as either conventional acute CVCs or antimicrobial acute CVCs. The acute CVC market includes conventional ...

European Market Report for Implantable Ports 2017 - MedCore

European Market Report for Implantable Ports 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description Implantable ports are reservoirs that are implanted into the body and connected to the superior vena cava (SVC) by a catheter. These devices require an invasive surgical implantation by vascula ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.